// App-Quantinova.ai

GS5-01 : Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer: A multi-center pooled analysis

Researchers

Presenter

  • Christina Yau

Principal Investigators

  • Jane Wei

  • Marie Osdoit

  • Fabien Reyal

  • Anne-Sophie Hamy

  • Marick Lae

  • Miguel Martin

  • Maria del Monte

  • Rebekah Gould

  • Jelle Wesseling

  • Tessa Steenbruggen

  • Maartje van Seijen

  • Gabe Sonke

  • Stephen Edge

  • Stephen-John Sammut

  • Elena Provenzano

  • Jean Abraham

  • Peter Hall

  • Ashley Graham

  • Lorna Mackintosh

  • David Cameron

  • Alice Wang

  • Priyanka Sharma

  • Kimberly Cole

  • Lajos Pusztai

  • Mi-Ok Kim

  • Laura van t Veer

  • Laura Esserman

  • W. Fraser Symmans

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Institut Curie, Paris Cedex, France

  • Instituto de investigacion sanitaria gregorio maranon, Madrid, Spain

  • Mayo Clinic, Rochester, MN

  • 1.MD Anderson Cancer Center, Houston, TX

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • University of Cambridge, Cambridge, United Kingdom

  • University of Kansas, Kansas City, KS

  • Yale University, New Haven, CT

  • Yale University, New Haven, CT

Locations

  • United States

  • France

  • Spain

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved